Predictors of affect following treatment decision‐making for prostate cancer: conversations, cognitive processing, and coping

Christie, Kysa M.; Meyerowitz, Beth E.; Giedzinska-Simons, Antoinette; Gross, Mitchell E.; Agus, David B.

doi:10.1002/pon.1420

Cited by 41 publications

(32 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although research suggests that both problem-focused coping and meaning-focused coping are helpful (e.g., Christie, Meyerowitz, Giedzinska-Simons, Gross, & Agus, 2008, Tomaka, Blascovitch, Kelsey, & Leitten, 1993, and are mediators of the appraisal-adjustment link, very little research has directly pitted the effects of these two types of coping in the same study within the context of appraisals and adjustment. Additionally, no studies to our knowledge have compared the helpfulness of problem-focused and meaningfocused coping as mediators between appraisal and adjustment within the context of ongoing stressors.…”

Section: The Current Study: Problem-focused Vs Meaning-focused Copingmentioning

confidence: 96%

Problem-Focused Vs. Meaning-Focused Coping as Mediators of the Appraisal-Adjustment Relationship in Chronic Stressors

Riley¹,

Park²

2014

Journal of Social and Clinical Psychology

View full text Add to dashboard Cite

Section: The Current Study: Problem-focused Vs Meaning-focused Copingmentioning

confidence: 96%

Problem-Focused Vs. Meaning-Focused Coping as Mediators of the Appraisal-Adjustment Relationship in Chronic Stressors

Riley¹,

Park²

2014

Journal of Social and Clinical Psychology

View full text Add to dashboard Cite

“…11 Advice from others also has been linked to patients' perceptions of greater social support and increased emotional expression after decision-making. 41 Messages and communication that provide tangible assistance and reassurance and medical information in a language that patients understand were associated with the patient's treatment decision and decision-making process. 42 It is possible that patients who have received more treatment-related advice from others believe that their treatment decision has been influenced more by others, especially by their physician(s), but less by themselves than what actually has happened.…”

Section: Discussionmentioning

confidence: 99%

Who makes the decision regarding the treatment of clinically localized prostate cancer–the patient or physician?

Song

Chen

Bensen

et al. 2012

Cancer

View full text Add to dashboard Cite

BACKGROUND:The current study examined how patients' sociodemographic, cancer-related, and subjective affective factors impacted their role in treatment decision-making. METHODS: The patient sample (N ¼ 788) was taken from a prospective follow-up study of a population-based cohort. Participants included 343 African American and 445 Caucasian-American patients with clinically localized prostate cancer. Multinomial logistic regression was used to investigate relations between the explanatory variables and the nominal 3-level decision-making variable: patient-only, patient-physician shared, and physician-only. RESULTS: Approximately 41% of patients reported patient-only decision-making, 45% reported shared decision-making, and 13% reported physician-only decisionmaking. The odds of patient-only over physician-only decision-making were greater for younger men (vs those aged 65 years) (odds ratio [OR], 1.68; 95% confidence interval [95% CI], 1.03-2.74), and were less for men with high (vs low) cancer aggressiveness (OR,0.29; 95% CI, 0.15-0.55). The odds of shared over physician-only decision-making were less for men with high (vs low) cancer aggressiveness (OR, 0.40; 95% CI, 0.22-0.73). Greater odds of patient-only and shared decision-making also were found to be associated with greater concerns about the physical impact of treatment and having enough time for decision-making and lower scores of receiving advice from others. CONCLUSIONS: The findings of the current study indicate that, to facilitate a more patient-oriented decision-making process regarding treatment in those with clinically localized prostate cancer, clinicians need to tailor their interventions according to patient age and cancer aggressiveness, help reduce patient concerns and misconceptions regarding the physical impact of treatments, allow sufficient time for patients to consider treatment options, and assist patients in balancing advice and information received from different sources. Cancer 2013;119:421-8.

show abstract

“…Together, these data strongly suggest that AAT side effects are a potential pathway between AAT and clinical levels of anxiety (the presence of a similar link with depression requires replication with a larger sample, although the size of the correlation suggests that such a link exists). If, as has been demonstrated previously, elevated anxiety and depression contribute to impaired decision making and place limitations on treatment efficacy with PCa patients (Christie et al, 2009;Thomas et al, 2009), then AAT side effects may be an instigator factor in that process.…”

Section: Discussionmentioning

confidence: 92%

“…There is also evidence that elevated anxiety and depression in this patient group can have powerful and extended effects during the treatment phase by interfering with decision making (Christie, Meyerowitz, Giedzinska-Simons, Gross, & Agus, 2009), perhaps reducing the longer term success of treatment and further limiting patients' chances of recovery (Thomas, Thomas, Nandamohan, Nair, & Pandey, 2009). These data are in accord with those from a major metaanalysis based upon 25 studies of patients experiencing a range of illnesses (e.g., cancer, angina, end-stage renal disease, and arthritis), which showed that anxious and depressed patients are 3 times more likely to be noncompliant with their medication regime than nonanxious or nondepressed patients (DiMatteo, Lepper, & Croghan, 2000).…”

mentioning

confidence: 97%

Do Patient-Reported Androgen-Deprivation Therapy Side Effects Predict Anxiety and Depression Among Prostate Cancer Patients Undergoing Radiotherapy? Implications for Psychosocial Therapy Interventions

Sharpley¹,

Bitsika²,

Christie³

2012

Journal of Psychosocial Oncology

View full text Add to dashboard Cite

Antiandrogen therapy (AAT) is a common adjunct treatment for prostate cancer (PCa) patients and has shown significant benefits to long-term outcomes from radiation or surgery. Although AAT has some adverse side effects and data from breast cancer patients indicate that such side effects from hormonal therapies may contribute to anxiety and depression and may also hinder AAT treatment compliance, this issue has not been investigated within a sample of PCa patients. This study explores the incidence of AAT side effects in a sample of PCa patients, the links between those side effects and anxiety and depression, the possible ways in which these factors may contribute to AAT treatment noncompliance in PCa patients, and how psychosocial treatments might be developed to attend to this issue. 147 PCa patients completed questionnaires on demographic factors, treatment compliance, AAT side effects, anxiety and depression. About 18% of the sample reported AAT side effects, and there was a significant association between the presence of side effects and elevated anxiety and depression scores. Increased frequency of side effects was significantly associated with elevated anxiety, but not depression. The most powerful relationship between AAT side effects and anxiety-depression was for the subfactors of (1) Fatigue, Pain and Discomfort, and (2) Psychological Agitation and Pessimism. Although fatigue, pain, and discomfort may be outcomes of the hormonal treatment itself, psychological agitation and pessimism represent a discrete psychological pathway between AAT side effects and anxiety and depression and (potentially) treatment noncompliance. Methods of addressing patients' loss of optimism in their treatment outcomes are discussed.

show abstract

Predictors of affect following treatment decision‐making for prostate cancer: conversations, cognitive processing, and coping

Abstract: Greater time spent talking with family and friends about treatment options may provide opportunities for patients to cope with their cancer diagnosis and facilitate cognitive processing, which may improve patient distress over time.

Cited by 41 publications

References 23 publications

Problem-Focused Vs. Meaning-Focused Coping as Mediators of the Appraisal-Adjustment Relationship in Chronic Stressors

Problem-Focused Vs. Meaning-Focused Coping as Mediators of the Appraisal-Adjustment Relationship in Chronic Stressors

Who makes the decision regarding the treatment of clinically localized prostate cancer–the patient or physician?

Do Patient-Reported Androgen-Deprivation Therapy Side Effects Predict Anxiety and Depression Among Prostate Cancer Patients Undergoing Radiotherapy? Implications for Psychosocial Therapy Interventions

Contact Info

Product

Resources

About